Jsda get in now while before the street discovers this gem. The company achieved its highest-ever quarterly revenue of $11.7 million in Q4 2025, highlighting strong consumer demand and effective strategic initiatives.
Talk about your daily plays, ideas and strategies that do not warrant an actual post.
This is the place to request buy/sell advice from the community.
Remember to keep it civil.
Trade responsibly.
Here are a few top gainers from this week. Please let me know if I missed any other important ones, I mainly trade during premarket hours.
ELAB - This company has brought out a lot of news in the past 2 weeks:
March 24th: SVM Machining, Inc. Secures ITAR Registration, Enabling Entry into U.S. Defense Manufacturing Contracts
March 27th: NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments
March 31st: AGA Precision Systems Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products
April 2nd: PMGC Holdings Inc. Announces the Formation of New Subsidiary, NorthStrive Defense Tech to Target High-Growth Defense, Drone and Autonomous Systems Sector
CYCN: Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement (April 1st)
AGPU: Axe Compute Reports $12 Million in Executed Agreements Providing $835 Thousand in Estimated Monthly Income Entering Q2 2026 (April 1st)
GVH: Couldn't find the news.
SKYQ: Sky Quarry's Nevada Refinery Gains Strategic Value as Brent Crude Surpasses $110 and West Coast Refining Capacity Shrinks (April 2nd)
ARTL: News from the SEC, correct me if I'm wrong.
BFRG: BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder (April 30th)
I traded CYCN, ELAB, and BFRG and did really good this week, how did you guys do?
Zapata Quantum is impressive.
While most people are still waiting for “quantum someday,” Zapata (ZPTA) is already delivering real breakthroughs in medicine — right now.
After a full reset in 2024–2025, they’ve emerged stronger:
• 60+ global patents on their hardware-agnostic Quantum Intermediate Representation (QIR) platform
• Fresh pharma-heavy Growth Advisory Board (March 2026)
• Proven hybrid quantum-classical AI that outperformed classical models on KRAS cancer inhibitors — molecules long considered “undruggable”
• Long-standing collaborations with University of Toronto, Insilico Medicine, and St. Jude Children’s Research Hospital
Traditional drug discovery still costs $1B+ and 10–15 years. Zapata’s north star is turning quantum simulation power into faster, smarter, personalized medicine.
CEO Sumit Kapur is taking the story to eMerge Americas later this month in the “Quantum-Driven Drug Discovery” session.
This poster captures the full comeback + the massive opportunity ahead. Quantum in life sciences is no longer theoretical — it’s moving into the lab and the clinic.
What’s your take — biggest near-term impact of quantum in healthcare? 👇
For educational purposes only. Not investment advice. Always do your own research.
TSX hit all-time highs this year. The TSXV is still 65% below its 2021 peak.
I've been covering the profitable non-resource companies buried on this exchange for months. These are the ones Bay Street ignores because they share a listing with a thousand junior mining stocks. That coverage gap is the edge.
The setup right now:
The index is 65% off its highs through all of that. That doesn't stay forever.
Wrote a full breakdown of why I think 2026 is when this changes. Honest about the risks too. Link here.
Not investment advice.